The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Priscilla A. Hollander

Baylor Endocrine Center

Dallas

TX 75246

USA

[email]@baylorhealth.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Baylor Endocrine Center, Dallas, TX 75246, USA. 2012
  • Baylor Endocrine Center, Baylor University Medical Center, Dallas, USA. 2008 - 2011
  • Baylor University Medical Center, Department of Endocrinology, 3600 Gaston Avenue, Wadley 656, USA. 2007 - 2009
  • Ruth Collins Diabetes Center, Baylor University Medical Center at Dallas, Dallas, Texas 75246, USA. 2004 - 2009

References

  1. Controversies in prediabetes: do we have a diagnosis? Hollander, P., Spellman, C. Postgrad. Med (2012) [Pubmed]
  2. Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial. Hollander, P., Raslova, K., Skjøth, T.V., Råstam, J., Liutkus, J.F. Diabetes. Obes. Metab (2011) [Pubmed]
  3. Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: the ARPEGGIO trial. Hollander, P.A., Amod, A., Litwak, L.E., Chaudhari, U. Diabetes. Care (2010) [Pubmed]
  4. Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes. Hollander, P.A., Cefalu, W.T., Mitnick, M., Lawrence, D., Rosenstock, J. Diabetes Technol. Ther. (2010) [Pubmed]
  5. Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone. Hollander, P., Li, J., Allen, E., Chen, R. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  6. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes. Hollander, P., Cooper, J., Bregnhøj, J., Pedersen, C.B. Clin. Ther (2008) [Pubmed]
  7. Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes. Hollander, P.A. MedGenMed (2007) [Pubmed]
  8. Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus. Hollander, P. Am. J. Med. (2007) [Pubmed]
  9. Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials. Hollander, P.A., Krasner, A., Klioze, S., Schwartz, P., Duggan, W. Diabetes. Care (2007) [Pubmed]
  10. Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes. Hollander, P., Yu, D., Chou, H.S. Arch. Intern. Med. (2007) [Pubmed]
  11. Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. Hollander, P.A., Blonde, L., Rowe, R., Mehta, A.E., Milburn, J.L., Hershon, K.S., Chiasson, J.L., Levin, S.R. Diabetes. Care (2004) [Pubmed]
 
WikiGenes - Universities